Applied DNA Sciences, Inc. (NASDAQ: APDN), a biotechnology firm, has announced its ticker symbol on the Nasdaq Capital Market will change from “APDN” to “BNBX,” effective October 7, 2025, to reflect its new strategic focus on a BNB-based digital asset treasury strategy.
The company stated that the new ticker, BNBX, is intended to underscore its commitment to optimizing yield generation and token accumulation within the Binance ecosystem. This strategic pivot involves implementing a differentiated approach to treasury management.
This approach will integrate actively managed decentralized finance (DeFi) protocols and strategies specific to the Binance ecosystem. The primary objectives are to enhance capital efficiency, improve liquidity resilience, and gain exposure to the upside potential of digital assets.
Applied DNA Sciences noted that no action is required from its stockholders regarding this ticker symbol change. The company’s common stock will continue to be listed on Nasdaq, and its CUSIP number will remain unchanged.
Beyond its digital asset treasury strategy, Applied DNA Sciences continues its work in commercializing proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets.
